4SC AG
Biopharmaceutical company with no products under development or operational business.
VSC | F
Overview
Corporate Details
- ISIN(s):
- DE000A3E5C40
- LEI:
- 391200QOKN7LGVP0RQ86
- Country:
- Germany
- Address:
- Fraunhoferstr. 22, 82152 Planegg
- Website:
- https://www.4sc.com/
- Sector:
- Manufacturing
Description
4SC AG is a biopharmaceutical company that formerly focused on the research and development of small-molecule drugs for cancer treatment. The company's strategy centered on addressing diseases with high unmet medical needs by developing innovative therapies that targeted epigenetic mechanisms of action. According to the company's official statements, it currently has no products under development and no operational business.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2020-04-21 07:30 |
4SC provides Q1 2020 update
|
English | HTML • 10.9 KB | ||
| 2020-04-17 00:00 |
Annual financial report 2019
|
English | PDF • 1.1 MB | ||
| 2020-04-17 00:00 |
Annual financial report 2019
|
German | PDF • 1.1 MB | ||
| 2020-04-16 07:30 |
4SC AG: Conference call to be hosted on 21 April 2020 to present the Q1 report …
|
English | HTML • 9.3 KB | ||
| 2020-04-15 15:06 |
4SC AG: Bekanntmachung der Einberufung zur Hauptversammlung am 08.05.2020 in Pl…
|
German | HTML • 92.2 KB | ||
| 2020-04-08 07:30 |
4SC AG: FDA Accepts IND Application for MERKLIN 2 Study
|
English | HTML • 14.1 KB | ||
| 2020-03-25 07:30 |
4SC AG provides results for financial year 2019 and outlook
|
English | HTML • 13.2 KB | ||
| 2020-02-12 07:30 |
4SC to present at the World Congress of Cutaneous Lymphomas in Barcelona, Spain
|
English | HTML • 14.3 KB | ||
| 2020-01-31 07:30 |
4SC - Resminostat and RESMAIN Study Update
|
English | HTML • 16.5 KB | ||
| 2020-01-15 07:30 |
4SC AG: First Patient Enrolled in DONIMI Study Evaluating Domatinostat in the N…
|
English | HTML • 15.0 KB | ||
| 2020-01-09 07:30 |
4SC AG: 3 upcoming conferences
|
English | HTML • 8.4 KB | ||
| 2020-01-07 07:30 |
4SC AG enters into avelumab supply agreement with Merck KGaA, Darmstadt, German…
|
English | HTML • 13.8 KB | ||
| 2019-12-19 11:30 | English | HTML • 15.2 KB | |||
| 2019-12-19 11:15 | English | HTML • 4.9 KB | |||
| 2019-12-19 11:12 | English | HTML • 4.9 KB |
Automate Your Workflow. Get a real-time feed of all 4SC AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for 4SC AG
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for 4SC AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
